Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Diabetes Obes Metab. 2016 Jun 14;18(9):899–906. doi: 10.1111/dom.12686

Table 1.

Baseline study population characteristics

Outcome Status Over Follow-up
Overall (N=654)
Alive and did not experience an event (N=331)
Experienced an event (N=296)
Died without experiencing an event (N=27)
Mean (SD) or %
Mean (SD) or %
Mean (SD) or %
Mean (SD) or %
Age, years 58.1 (5.7) 57.3 (5.8) 58.9 (5.4) 60.3 (6.4)
Male 39% 32% 46% 41%
White 59% 59% 59% 67%
Education
 < HS 32% 30% 35% 22%
 HS or college 40% 38% 44% 33%
 > college 28% 32% 22% 44%
Current smoking 18% 18% 18% 33%
Current drinking 38% 38% 37% 56%
Physical activity 2.3 (0.7) 2.3 (0.7) 2.2 (0.7) 2.3 (0.9)
Family history of CVD* 57% 55% 57% 74%
Hypercholesterolemia 30% 25% 35% 26%
Statin use 3% 2% 4% 7%
BMI, kg/m2 30.7 (5.8) 30.4 (6.1) 31.4 (5.3) 28.2 (6.1)
Hypertension 57% 48% 67% 59%
Glucose-lowering medication
 Insulin 19% 17% 23% 19%
 Oral only 48% 43% 54% 48%
 None 32% 41% 23% 33%
Recent onset of diabetes 30% 32% 27% 44%

Abbreviations: BMI, body mass index; CVD, cardiovascular disease; HS, high school

*

Family history of CVD defined as self-reported parental history of stroke or CHD

Hypercholesterolemia was defined as total cholesterol ≥240 mg/dL or use of cholesterol-lowering medication.

Hypertension was defined as systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, or use of antihypertensive medication.